Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 15,132 | 5,332 | 8,545 | 4,913 | 8,345 |
| Gross Profit | 15,132 | 5,332 | 8,545 | 4,913 | 8,345 |
| Operating Expenses | 18,046 | 17,562 | 19,228 | 17,561 | 16,149 |
| Operating Income | -2,914 | -12,230 | -10,683 | -12,648 | -7,804 |
| Interest Expense | 0 | -23 | 0 | 0 | 0 |
| Other Income | 322 | 449 | 335 | 800 | 1,651 |
| Pre-tax Income | -2,592 | -11,758 | -10,348 | -11,848 | -6,153 |
| Income Tax | N/A | N/A | N/A | -164 | N/A |
| Net Income Continuous | -2,592 | -11,758 | -10,348 | -11,684 | -6,153 |
| Net Income | $-2,592 | $-11,758 | $-10,348 | $-11,684 | $-6,153 |
| EPS Basic Total Ops | -4.00 | -19.20 | -16.00 | -17.30 | -8.80 |
| EPS Basic Continuous Ops | -4.20 | -19.12 | -16.27 | -16.99 | -9.10 |
| EPS Diluted Total Ops | -4.00 | -19.20 | -16.00 | -17.30 | -8.80 |
| EPS Diluted Continuous Ops | -4.20 | -19.12 | -16.27 | -16.99 | -9.10 |
| EBITDA(a) | $-2,755 | $-12,188 | $-10,517 | $-12,483 | $-7,674 |